M3 GLOBAL RESEARCH Overview

M3 Inc. operates in the US, Asia, and Europe with over 3.5 million physician members globally via its portals including mdlinx.com, m3.com, Doctors.net.uk, medigate.net, M3 Medical and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (TYO:2413) with subsidiaries in major markets including USA, UK, Japan, South Korea, and China. Within the healthcare and the life science industry, M3 focuses on market research, medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services.

M3 Global Research, part of M3 Inc., provides the most comprehensive and highest quality market research recruitment and support services available to the industry with relationships reaching respondents in more than 70 countries worldwide.

M3 Global Research maintains ISO 26362 and 27001 certifications with the highest quality data collection and project management capabilities that cover the spectrum of quantitative and qualitative techniques utilized today. M3 services incorporate all of the most advanced statistical and attitudinal methodologies allowing clients to provide world-class offerings and support services to their end-client customers throughout multiple industry sectors.

Beyond healthcare providers, M3 Global Research creates and maintains relationships and panels of Patients, Caregivers, and general consumers.

M3 has offices in Tokyo, Washington D.C., Fort Washington, PA, Oxford, London, Beijing, and Seoul.